Yeast-derived particulate b-glucan treatment subverts the suppression of myeloid-derived suppressor cells (MDSC) by inducing polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer

Journal of Immunology

Volumn 196, Issue 5, 2016, Pages 2167-2180

  Albeituni, Sabrin H ^a   Ding, Chuanlin ^a   Liu, Min ^a   Hu, Xiaoling ^a   Luo, Fengling ^a   Kloecker, Goetz ^a   Bousamra, Michael ^a   Zhang, Huang Ge ^a   Yan, Jun ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; CD11B ANTIGEN; CD14 ANTIGEN; CD33 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DECTIN 1; DECTIN 1 RECEPTOR; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RECEPTOR; UNCLASSIFIED DRUG; YEAST DERIVED PARTICULATE BETA GLUCAN; LECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; BIOACCUMULATION; BONE MARROW CELL; CANCER SIZE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; LEWIS LUNG CARCINOMA CELL; MALIGNANT NEOPLASTIC DISEASE; MONOCYTE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NON SMALL CELL LUNG CANCER; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; RESPIRATORY BURST; SPLENOMEGALY; SUBCUTANEOUS TISSUE TUMOR; SUPPRESSOR CELL; ADULT; AGED; ANIMAL; C57BL MOUSE; CARCINOMA, NON-SMALL-CELL LUNG; CELL SEPARATION; CLINICAL TRIAL; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG NEOPLASMS; MALE; METABOLISM; MIDDLE AGED; MIXED LYMPHOCYTE CULTURE; NEUTROPHIL; REAL TIME POLYMERASE CHAIN REACTION; VERY ELDERLY; WESTERN BLOTTING; YEAST;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGEN-PRESENTING CELLS; APOPTOSIS; BETA-GLUCANS; BLOTTING, WESTERN; CARCINOMA, LEWIS LUNG; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; CELL SEPARATION; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HUMANS; LECTINS, C-TYPE; LUNG NEOPLASMS; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MONOCYTES; MYELOID CELLS; NEUTROPHILS; REAL-TIME POLYMERASE CHAIN REACTION; YEASTS;

EID: 84962026544     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501853     Document Type: Article

References (50)

1. Dunn, G. P., A. T. Bruce, H. Ikeda, L. J. Old, and R. D. Schreiber. 2002. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3: 991-998.
2. Dunn, G. P., L. J. Old, and R. D. Schreiber. 2004. The three Es of cancer immunoediting. Annu. Rev. Immunol. 22: 329-360.
3. Schreiber, R. D., L. J. Old, and M. J. Smyth. 2011. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331: 1565-1570.
4. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
5. Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
6. Movahedi, K., M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, and J. A. Van Ginderachter. 2008. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111: 4233-4244.
7. Corzo, C. A., T. Condamine, L. Lu, M. J. Cotter, J. I. Youn, P. Cheng, H. I. Cho, E. Celis, D. G. Quiceno, T. Padhya, et al. 2010. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207: 2439-2453.
8. Youn, J. I., V. Kumar, M. Collazo, Y. Nefedova, T. Condamine, P. Cheng, A. Villagra, S. Antonia, J. C. McCaffrey, M. Fishman, et al. 2013. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat. Immunol. 14: 211-220.
9. Heuvers, M. E., F. Muskens, K. Bezemer, M. Lambers, A. M. Dingemans, H. J. Groen, E. F. Smit, H. C. Hoogsteden, J. P. Hegmans, and J. G. Aerts. 2013. Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients. Lung Cancer 81: 468-474.
10. Solito, S., I. Marigo, L. Pinton, V. Damuzzo, S. Mandruzzato, and V. Bronte. 2014. Myeloid-derived suppressor cell heterogeneity in human cancers. Ann. N. Y. Acad. Sci. 1319: 47-65.
11. Bronte, V., M. Wang, W. W. Overwijk, D. R. Surman, F. Pericle, S. A. Rosenberg, and N. P. Restifo. 1998. Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J. Immunol. 161: 5313-5320.
12. Gabrilovich, D. I., M. P. Velders, E. M. Sotomayor, and W. M. Kast. 2001. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J. Immunol. 166: 5398-5406.
13. Li, H., Y. Han, Q. Guo, M. Zhang, and X. Cao. 2009. Cancer-expanded myeloidderived suppressor cells induce anergy of NK cells through membrane-bound TGF-β1. J. Immunol. 182: 240-249.
14. Serafini, P., S. Mgebroff, K. Noonan, and I. Borrello. 2008. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 68: 5439-5449.
15. Srivastava, M. K., P. Sinha, V. K. Clements, P. Rodriguez, and S. Ostrand- Rosenberg. 2010. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res. 70: 68-77.
16. Gabrilovich, D. I., S. Ostrand-Rosenberg, and V. Bronte. 2012. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12: 253-268.
17. Albeituni, S. H., C. Ding, and J. Yan. 2013. Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer. Cancer J. 19: 490-501.
18. Kerrigan, A. M., and G. D. Brown. 2010. Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs. Immunol. Rev. 234: 335-352.
19. Goodridge, H. S., C. N. Reyes, C. A. Becker, T. R. Katsumoto, J. Ma, A. J. Wolf, N. Bose, A. S. Chan, A. S. Magee, M. E. Danielson, et al. 2011. Activation of the innate immune receptor Dectin-1 upon formation of a "phagocytic synapse". Nature 472: 471-475.
20. Qi, C., Y. Cai, L. Gunn, C. Ding, B. Li, G. Kloecker, K. Qian, J. Vasilakos, S. Saijo, Y. Iwakura, et al. 2011. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans. Blood 117: 6825-6836.
21. Tian, J., J. Ma, K. Ma, H. Guo, S. E. Baidoo, Y. Zhang, J. Yan, L. Lu, H. Xu, and S. Wang. 2013. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells. Eur. J. Immunol. 43: 1220-1230.
22. Saijo, S., N. Fujikado, T. Furuta, S. H. Chung, H. Kotaki, K. Seki, K. Sudo, S. Akira, Y. Adachi, N. Ohno, et al. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol. 8: 39-46.
23. Brown, G. D., and S. Gordon. 2001. Immune recognition. A new receptor for β-glucans. Nature 413: 36-37.
24. Li, B., D. J. Allendorf, R. Hansen, J. Marroquin, C. Ding, D. E. Cramer, and J. Yan. 2006. Yeast β-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. J. Immunol. 177: 1661-1669.
25. Vowells, S. J., S. Sekhsaria, H. L. Malech, M. Shalit, and T. A. Fleisher. 1995. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J. Immunol. Methods 178: 89-97.
26. Walrand, S., S. Valeix, C. Rodriguez, P. Ligot, J. Chassagne, and M. P. Vasson. 2003. Flow cytometry study of polymorphonuclear neutrophil oxidative burst: a comparison of three fluorescent probes. Clin. Chim. Acta 331: 103-110.
27. Li, B., Y. Cai, C. Qi, R. Hansen, C. Ding, T. C. Mitchell, and J. Yan. 2010. Orally administered particulate β-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer. Clin. Cancer Res. 16: 5153-5164.
28. Kusmartsev, S., S. Nagaraj, and D. I. Gabrilovich. 2005. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells. J. Immunol. 175: 4583-4592.
29. Gallina, G., L. Dolcetti, P. Serafini, C. De Santo, I. Marigo, M. P. Colombo, G. Basso, F. Brombacher, I. Borrello, P. Zanovello, et al. 2006. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116: 2777-2790.
30. Nagaraj, S., and D. I. Gabrilovich. 2008. Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Res. 68: 2561-2563.
31. Huang, A., B. Zhang, B. Wang, F. Zhang, K. X. Fan, and Y. J. Guo. 2013. Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. Cancer Immunol. Immunother. 62: 1439-1451.
32. Liu, C. Y., Y. M. Wang, C. L. Wang, P. H. Feng, H. W. Ko, Y. H. Liu, Y. C. Wu, Y. Chu, F. T. Chung, C. H. Kuo, et al. 2010. Population alterations of L-arginaseand inducible nitric oxide synthase-expressed CD11b+/CD14-/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. J. Cancer Res. Clin. Oncol. 136: 35-45.
33. Kusmartsev, S., Y. Nefedova, D. Yoder, and D. I. Gabrilovich. 2004. Antigenspecific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172: 989-999.
34. Corzo, C. A., M. J. Cotter, P. Cheng, F. Cheng, S. Kusmartsev, E. Sotomayor, T. Padhya, T. V. McCaffrey, J. C. McCaffrey, and D. I. Gabrilovich. 2009. Mechanism regulating reactive oxygen species in tumor-induced myeloidderived suppressor cells. J. Immunol. 182: 5693-5701.
35. Fridlender, Z. G., J. Sun, S. Kim, V. Kapoor, G. Cheng, L. Ling, G. S. Worthen, and S. M. Albelda. 2009. Polarization of tumor-associated neutrophil phenotype by TGF-β: "N1" versus "N2" TAN. Cancer Cell 16: 183-194.
36. Li, X., A. Utomo, X. Cullere, M. M. Choi, D. A. Milner, Jr., D. Venkatesh, S. H. Yun, and T. N. Mayadas. 2011. The β-glucan receptor Dectin-1 activates the integrin Mac-1 in neutrophils via Vav protein signaling to promote Candida albicans clearance. Cell Host Microbe 10: 603-615.
37. Nefedova, Y., S. Nagaraj, A. Rosenbauer, C. Muro-Cacho, S. M. Sebti, and D. I. Gabrilovich. 2005. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the Janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Res. 65: 9525-9535.
38. Hong, F., J. Yan, J. T. Baran, D. J. Allendorf, R. D. Hansen, G. R. Ostroff, P. X. Xing, N. K. Cheung, and G. D. Ross. 2004. Mechanism by which orally administered β-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 173: 797-806.
39. Yang, L., L. M. DeBusk, K. Fukuda, B. Fingleton, B. Green-Jarvis, Y. Shyr, L. M. Matrisian, D. P. Carbone, and P. C. Lin. 2004. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6: 409-421.
40. Ma, G., P. Y. Pan, S. Eisenstein, C. M. Divino, C. A. Lowell, T. Takai, and S. H. Chen. 2011. Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 34: 385-395.
41. Yu, H., D. Pardoll, and R. Jove. 2009. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9: 798-809.
42. Dillon, S., S. Agrawal, K. Banerjee, J. Letterio, T. L. Denning, K. Oswald- Richter, D. J. Kasprowicz, K. Kellar, J. Pare, T. van Dyke, et al. 2006. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigenpresenting cells and immunological tolerance. J. Clin. Invest. 116: 916-928.
43. Karumuthil-Melethil, S., R. Gudi, B. M. Johnson, N. Perez, and C. Vasu. 2014. Fungal β-glucan, a Dectin-1 ligand, promotes protection from type 1 diabetes by inducing regulatory innate immune response. J. Immunol. 193: 3308-3321.
44. Garaulet, G., A. Alfranca, M. Torrente, A. Escolano, R. López-Fontal, S. Hortelano, J. M. Redondo, and A. Rodríguez. 2013. IL10 released by a new inflammation-regulated lentiviral system efficiently attenuates zymosan-induced arthritis. Mol. Ther. 21: 119-130.
45. Raychaudhuri, B., P. Rayman, J. Ireland, J. Ko, B. Rini, E. C. Borden, J. Garcia, M. A. Vogelbaum, and J. Finke. 2011. Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. Neurooncol. 13: 591-599.
46. Sippel, T. R., J. White, K. Nag, V. Tsvankin, M. Klaassen, B. K. Kleinschmidt- DeMasters, and A. Waziri. 2011. Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin. Cancer Res. 17: 6992-7002.
47. Brandau, S., S. Trellakis, K. Bruderek, D. Schmaltz, G. Steller, M. Elian, H. Suttmann, M. Schenck, J. Welling, P. Zabel, and S. Lang. 2011. Myeloidderived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J. Leukoc. Biol. 89: 311-317.
48. Diaz-Montero, C. M., M. L. Salem, M. I. Nishimura, E. Garrett-Mayer, D. J. Cole, and A. J. Montero. 2009. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol. Immunother. 58: 49-59.
49. Almand, B., J. I. Clark, E. Nikitina, J. van Beynen, N. R. English, S. C. Knight, D. P. Carbone, and D. I. Gabrilovich. 2001. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166: 678-689.
50. Iclozan, C., S. Antonia, A. Chiappori, D. T. Chen, and D. Gabrilovich. 2013. Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer. Cancer Immunol. Immunother. 62: 909-918.